A CLINICAL PLAN FOR MDMA (ECSTASY) IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER (PTSD): PARTNERING WITH THE FDA
Saved in:
DOBLIN, R., A CLINICAL PLAN FOR MDMA (ECSTASY) IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER (PTSD): PARTNERING WITH THE FDA. JOURNAL OF PSYCHOACTIVE DRUGS, Vol. 34, no. 2 (2002), p. 185-194.
Ref.
118131
Location:
SIIS R.829 Archivo
Palabras clave:
Drogodependencias, Enfermedades mentales, Estrés, Éxtasis, Fármacos, Innovaciones, Terapia, Tratamiento, Trauma, España, EE.UU.
Drogodependencias, Enfermedades mentales, Estrés, Éxtasis, Fármacos, Innovaciones, Terapia, Tratamiento, Trauma, España, EE.UU.
Similar Items: A CLINICAL PLAN FOR MDMA (ECSTASY) IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER (PTSD): PARTNERING WITH THE FDA
- MDMA. ASSISTED PSYCHOTHERAPY USING LOW DOSES IN A SMALL SAMPLE OF WOMEN WITH CHRONIC POSTTRAUMATIC STRESS DISORDER
- ALCOHOL DEPENDENCE AND POSTTRAUMATIC STRESS DISORDER: DIFFERENCES IN CLINICAL PRESENTATION AND RESPONSE TO COGNITIVE-BEHAVIORAL THERAPY BY ORDER OF ONSET
- POSTTRAUMATIC STRESS DISORDER IN HOSPITALIZED ADOLESCENTS: PSYCHIATRIC COMORBIDITY AND CLINICAL CORRELATES
- A mixed‐methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM‐5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities
- COGNITIVE-BEHAVIORAL PSYCHOTHERAPY FOR CHILDREN AND ADOLESCENTS WITH POSTTRAUMATIC STRESS DISORDER AFTER A SINGLE-INCIDENT STRESSOR
- TREATING SEXUALLY ABUSED CHILDREN WITH POSTTRAUMATIC STRESS SYMPTOMS: A RANDOMIZED CLINICAL TRIAL